Insights
Specialty and Weight Loss Webinar
Hear how weight loss drugs are shaping traditional and specialty spend.
4 key forces shaping the future of pharmacy
These emerging trends will help define the road ahead.
Weighty issue: How to contain GLP-1 costs
Get strategies for handling the new anti-obesity medications.
How to manage blockbuster anti-obesity drugs
The pricey weight management drugs work well, but users need coaching and support to maintain the benefits.
How our medication packaging helps the planet
New packaging saves CO2, water, energy, and plastic waste.
GLP-1 agonists: A new class of weight loss medications
In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.
Regulations to watch: Spring 2024
Get the latest on legislation impacting PBM operations.
New Client onboarding in Florida
Download this step-by-step guide for client onboarding.
How to control drug costs without compromising care
Explore three principles driving better pharmacy benefit decisions.
Empowering clients with more choice and transparency
Helping make prescription drugs more affordable for plan sponsors and the members we serve is a universal focus.
Health Equity Vision Into Action Report
Learn how identifying and addressing disparities in health care allows everyone to live their healthiest life.
Addressing pharmacy issues that matter to you
From specialty pharmacy to drug affordability, our experts tackle your biggest pharmacy challenges.
Regulatory updates with Optum Rx
Stay up-to-date on what’s happening in pharmacy legislation.
Alternative funding: Real savings or problems?
See how much "free" drugs will actually cost you.
Drugs to Watch in summer 2023: New therapies
New drugs for postpartum depression, dermatitis and blindness are coming.
Exciting advances for sickle cell, chronic obesity, Alzheimer’s
See potential cures for sickle cell and new help for chronic obesity and Alzheimer’s, along with how they work and how much they cost.
Transforming the pharmacy industry with transparency
Hear how the industry’s most transparent and independent Pharmacy & Therapeutics Committee evaluates drugs for the Optum Rx formulary.
Orphan drugs market: Can we afford them?
We examine key questions around orphan drugs such as why they're so expensive, how they're being used and what plan sponsors should do next.
Advancing health equity: How Optum Rx Is overcoming challenges
Thought leaders discuss the intentional vigilance needed to overcome obstacles impeding better access to health care for all.
3 new first-in-class therapies coming
See how innovation is driving the latest product development.
What to consider about weight loss drugs
Get the most from these pricey new obesity drugs by choosing the right coverage strategy and helping your members build lifelong habits.
Four myths: Carving out specialty pharmacy
Integrating specialty pharmacy means better care, lower costs.
3 steps to slash medication costs
This is your guide to reducing your health care spending.
Supporting Youth Mental Health: On-Demand Webinar
Dr. Yusra Benhalim shares insights on the challenges we must overcome to reach youth.
Get ahead of 3 pharmacy trends that will affect your plan
Find out what’s changing the pharmacy market and how it could impact you.
Drug pricing spotlight: Wound care
Combat against brand name products costing 125 times more.
Managing diabetes gains an 8:1 return on investment
Learn how a third-party administrator’s client improved health outcomes and lowered costs.
How to eliminate prescription waste
Achieve savings by targeting expensive, low-value drugs.
Optum Rx customer obsession video
How one Optum Rx employee made the system work better for everyone
Creating connections through partnerships
Hear from an Optum Rx client on how we're partnering together for everyone we serve.
Biosimilars to save billions in this decade
Prices for popular brand-name biologics drop up to 60% with generic-equivalent biosimilars.
How to manage medication overload
Hear from a leader's perspective on how to manage polypharmacy.
The secret to lowering the total cost of care
Rising pharmacy costs concern everyone. Managing the underlying health conditions behind each prescription is key to addressing these high costs.
Personalized care: Focusing on the member
Hear from Optum Rx chief of operations, Jon Mahrt
Which rules will impact pharmacy in 2023?
2023 is already a busy year for pharmacy regulation. Read about the latest regulations that could impact you and your pharmacy benefit plan.
Balancing health choices, cost and outcomes
The health care system has fewer resources than ever and struggles to provide care when and where people need it. How can employers support their workforces?
Rules impacting pharmacy: Summer 2023 legislative sessions
Learn what's at stake as the Senate considers PBM legislation.
What’s changing the PBM industry?
In this conversation, learn from Optum Rx thought leaders on how access, affordability and transparency have become imperatives for pharmacy benefit management.
First big drugs for 2024
New treatments for NASH, schizophrenia and more are on the way.
Pharmacy Insights Podcast
Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.
Smart formulary management
Developing and managing formularies that bring clinical and financial value
Case Study: Advanced Pharmacy Audit Services
How a health plan saved more than $1 million
Keeping your data secure is mission critical
See how we help prevent costly, disruptive cyberattacks.
Gene therapies: Can we afford the future of medicine?
Learn how to manage financial risk as gene therapies become more commonplace.
3 new drugs to watch this fall
As the year begins to close, we highlight three essential pipeline drugs with an expected U.S. Food and Drug Administration (FDA) decision this fall.
5 questions: Premium Value formulary
Hear from OptumRx SVP of clinical & formulary services
The next biosimilar wave has arrived. Now what?
In this conversation, learn about a new class of biosimilars and what this means for competition, cost and volume in the PBM market.
Using data to improve health equity
Together, we can identify disparities and take steps toward health equity for all Americans.
Lowest net cost and your bottom line
Learn about strategies to achieve the lowest net cost of prescription drugs through formularies, biosimilars and our Vigilant Drug Program.
Is your pharmacy benefit manager delivering value?
4 key questions you should be asking.
Experts agree: PBMs add value, lower costs
PBMs don’t cause high drug costs — they’re part of the solution. Our drug prices beat the “low cost” vendors.
5 trends that defined pharmacy in 2023
See which trends are shaping the present and future of pharmacy care services.
3 ways to deal with escalating drug costs
Innovations custom built for today’s specialty challenges.
3 ways to address vaccine fatigue
Learn about researched vaccine messaging themes and important steps you can take to promote critical vaccinations for members.
Optum Rx Drug Pipeline Insights Reports
Read the most recent quarterly reports on new drugs coming down the pipeline.
Unlocking the promise of personal medicine
See how a peek at your genes enables more precise prescribing.
Medicare enrollment: How a licensed insurance agent can help
Redefining the prior authorization process
How we are revamping the prescribing process
4 new drugs to watch this year
Breakthrough treatments for menopause, Alzheimer's and hemophilia are coming.
2024: A new year promises a host of new drugs
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what’s coming this year.
Specialty drug prices giving you sticker shock?
See how Specialty Compass defuses exploding drug costs.
Regulations to watch: Fall 2023
Learn what's at stake as the PBM legislation advances on Capitol Hill.
5 questions: Optum Rx chief pharmacy officer
Michael Einodshofer addresses the risks, challenges and opportunities facing the industry.
Slowing the specialty pharmacy carve-out stampede
Alzheimer's treatment: Time for a level-set?
See success rates, risks and costs of the new Alzheimer’s treatments.
Top